When a purchasing manager asks for "glandular liver powder," they're often describing three different products depending on who they're buying from. Spray-dried. Desiccated. Lyophilized. The terminology gets used interchangeably in ingredient catalogs, but the underlying processes diverge dramatically — and those differences matter at the level of what's left in the drum when it arrives at your facility.
This article lays out what each method actually does to tissue, why the distinction matters for formulators working with heat-sensitive compounds, and what questions to ask your supplier before assuming you're getting what the spec sheet describes.
Three methods, three outcomes
Glandular tissue is complex biological material. It contains proteins, co-factors, lipids, and peptides that can degrade with heat, oxidation, or prolonged moisture exposure. The processing method determines how much of that complexity survives.
Spray drying
The fastest and cheapest method. Liquid slurry is atomized into a hot chamber (typically 150–200°C inlet temperature), droplets dehydrate in seconds, and powder falls to a collection chamber. Throughput is high. Cost is low. What you lose are heat-labile compounds — anything that denatures below the temperature the atomized droplet reaches before it dries. Enzymes are largely deactivated. Some lipid fractions oxidize. The powder is fine, flowable, and carries well. It's also the least information-dense option from a biochemical standpoint.
Desiccation (low-heat air drying)
A step up from spray drying. Tissue is dried at lower temperatures — typically below 70°C — over longer periods. Heat damage is reduced. The resulting powder retains more of the original tissue's character than a spray-dried product, but desiccation still applies sustained heat and can alter thermally sensitive fractions. It's common in the supplement industry and is often what "desiccated liver" on a finished-product label refers to.
Lyophilization (freeze-drying)
The most information-preserving method. Fresh tissue is frozen at very low temperatures — often below –40°C — then placed in a vacuum chamber where pressure drops below the triple point of water. In this environment, ice sublimates directly to vapor without passing through a liquid phase. The tissue's biological architecture is preserved without heat exposure. The result is a porous matrix that reconstitutes readily and retains more of the original tissue's molecular integrity than any wet or heat-based method.
"The processing method isn't a footnote — it's the premise. A COA that lists moisture content and microbial results tells you the product is safe, not what survived to get there."
Elite Glandulars Technical TeamWhat the COA doesn't tell you
Most certificates of analysis cover identity, moisture, microbial limits, and heavy metals. These are safety checks. They confirm the material is what it says it is and that it's clean. What they don't confirm is the processing method's fidelity to the original tissue — unless the supplier runs additional characterization testing.
A lyophilized product and a spray-dried product from the same tissue source can pass identical COA parameters. The difference shows up in downstream testing: enzyme activity assays, amino acid profiles, or phospholipid characterization — tests that most ingredient buyers don't run at intake because they're expensive and slow.
Carrier-free vs. carrier-assisted powders
Processing method is one variable. Carrier addition is another. Maltodextrin is the most common carrier in spray-dried glandulars — it improves flowability, reduces hygroscopicity, and makes the powder easier to work with at scale. It's also diluting your active material and adding carbohydrate mass to a formula that may not benefit from it.
Carrier-free lyophilized glandulars are denser, stickier, and more demanding to work with — but the gram-for-gram concentration is higher, and the label is cleaner. For formulators targeting specific inclusion rates or marketing carrier-free status to end consumers, this matters.
Asking the right questions
If you're evaluating suppliers, these are the questions that separate a process claim from a documented reality:
- What is the inlet temperature during drying, or what is the chamber temperature and pressure profile during lyophilization?
- Is the tissue fresh-frozen before processing, or is it pre-dried or rendered?
- Does the COA include any activity testing beyond standard identity and safety panels?
- Is carrier material added, and if so, at what ratio?
- Can you provide a process description or SOP excerpt for audit purposes?
A supplier with a defensible process answers these directly. One whose process can't withstand scrutiny will deflect toward certifications and marketing language. The certificate of analysis is the floor, not the ceiling. What you're looking for is a supplier who treats documentation as an ongoing discipline, not a regulatory checkbox.
Elite Glandulars provides complete process transparency for all lyophilized SKUs, including tissue sourcing, cold-chain handling documentation, and chamber cycle data on request. If you're building a formula where processing integrity matters, that's where the conversation should start.